 |
 |
 |
|
 |
|||||
|
|||||||||
 |
|||||||||
|
|
 |
|
|
|
* Note: Draft guidances are undergoing finalization. Please contact the relevant division for the most up-to-date Agency perspective on an issue. For information on how to electronically submit a comment on a draft guidance, please see http://www.fda.gov/opacom/backgrounders/voice.html
Date created: August 15, 2006 |
|
|
|
||||||
 |
||||||
|
|
||||||